920 related articles for article (PubMed ID: 25804925)
1. Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia.
Liang J; Qi Z; Liu W; Wang P; Shi W; Dong W; Ji X; Luo Y; Liu KJ
Stroke; 2015 May; 46(5):1344-1351. PubMed ID: 25804925
[TBL] [Abstract][Full Text] [Related]
2. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia.
Liu W; Hendren J; Qin XJ; Liu KJ
Stroke; 2009 Jul; 40(7):2526-31. PubMed ID: 19478225
[TBL] [Abstract][Full Text] [Related]
3. Normobaric Hyperoxia Reduces Blood Occludin Fragments in Rats and Patients With Acute Ischemic Stroke.
Shi S; Qi Z; Ma Q; Pan R; Timmins GS; Zhao Y; Shi W; Zhang Y; Ji X; Liu KJ
Stroke; 2017 Oct; 48(10):2848-2854. PubMed ID: 28931617
[TBL] [Abstract][Full Text] [Related]
4. Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model.
Ma Y; Li L; Kong L; Zhu Z; Zhang W; Song J; Chang J; Du G
Biomed Res Int; 2018; 2018():8943210. PubMed ID: 29850586
[TBL] [Abstract][Full Text] [Related]
5. Normobaric hyperoxia attenuates early blood-brain barrier disruption by inhibiting MMP-9-mediated occludin degradation in focal cerebral ischemia.
Liu W; Hendren J; Qin XJ; Shen J; Liu KJ
J Neurochem; 2009 Feb; 108(3):811-20. PubMed ID: 19187098
[TBL] [Abstract][Full Text] [Related]
6. Normobaric hyperoxia inhibits NADPH oxidase-mediated matrix metalloproteinase-9 induction in cerebral microvessels in experimental stroke.
Liu W; Sood R; Chen Q; Sakoglu U; Hendren J; Cetin O; Miyake M; Liu KJ
J Neurochem; 2008 Dec; 107(5):1196-205. PubMed ID: 18786175
[TBL] [Abstract][Full Text] [Related]
7. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model.
Zarisfi M; Allahtavakoli F; Hassanipour M; Khaksari M; Rezazadeh H; Allahtavakoli M; Taghavi MM
Brain Res Bull; 2017 Sep; 134():85-90. PubMed ID: 28710023
[TBL] [Abstract][Full Text] [Related]
8. Oxygen therapy reduces secondary hemorrhage after thrombolysis in thromboembolic cerebral ischemia.
Sun L; Zhou W; Mueller C; Sommer C; Heiland S; Bauer AT; Marti HH; Veltkamp R
J Cereb Blood Flow Metab; 2010 Sep; 30(9):1651-60. PubMed ID: 20424638
[TBL] [Abstract][Full Text] [Related]
9. Effects of tissue plasminogen activator on cerebral microvessels of rats during focal cerebral ischemia and reperfusion.
Yang DY; Pan HC; Chen CJ; Cheng FC; Wang YC
Neurol Res; 2007 Apr; 29(3):274-82. PubMed ID: 17509227
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with normobaric oxygen (NBO) plus thrombolysis in experimental ischemic stroke.
Fujiwara N; Murata Y; Arai K; Egi Y; Lu J; Wu O; Singhal AB; Lo EH
BMC Neurosci; 2009 Jul; 10():79. PubMed ID: 19604385
[TBL] [Abstract][Full Text] [Related]
11. Bryostatin extends tPA time window to 6 h following middle cerebral artery occlusion in aged female rats.
Tan Z; Lucke-Wold BP; Logsdon AF; Turner RC; Tan C; Li X; Hongpaison J; Alkon DL; Simpkins JW; Rosen CL; Huber JD
Eur J Pharmacol; 2015 Oct; 764():404-412. PubMed ID: 26189021
[TBL] [Abstract][Full Text] [Related]
12. Ascorbic Acid Reduces the Adverse Effects of Delayed Administration of Tissue Plasminogen Activator in a Rat Stroke Model.
Allahtavakoli M; Amin F; Esmaeeli-Nadimi A; Shamsizadeh A; Kazemi-Arababadi M; Kennedy D
Basic Clin Pharmacol Toxicol; 2015 Nov; 117(5):335-9. PubMed ID: 25899606
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N
PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667
[TBL] [Abstract][Full Text] [Related]
14. Normobaric Hyperoxia Extends Neuro- and Vaso-Protection of N-Acetylcysteine in Transient Focal Ischemia.
Liu Y; Liu WC; Sun Y; Shen X; Wang X; Shu H; Pan R; Liu CF; Liu W; Liu KJ; Jin X
Mol Neurobiol; 2017 Jul; 54(5):3418-3427. PubMed ID: 27177548
[TBL] [Abstract][Full Text] [Related]
15. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion.
Pfefferkorn T; Rosenberg GA
Stroke; 2003 Aug; 34(8):2025-30. PubMed ID: 12855824
[TBL] [Abstract][Full Text] [Related]
16. Whole body hypothermia extends tissue plasminogen activator treatment window in the rat model of embolic stroke.
Hassanipour M; Zarisfi M; Ehsani V; Allahtavakoli M
Life Sci; 2020 Sep; 256():117450. PubMed ID: 32087233
[TBL] [Abstract][Full Text] [Related]
17. Spatiotemporal evolution of blood brain barrier damage and tissue infarction within the first 3h after ischemia onset.
Jin X; Liu J; Yang Y; Liu KJ; Yang Y; Liu W
Neurobiol Dis; 2012 Dec; 48(3):309-16. PubMed ID: 22813865
[TBL] [Abstract][Full Text] [Related]
18. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase activation and blood-brain barrier breakdown following thrombolysis.
Kelly MA; Shuaib A; Todd KG
Exp Neurol; 2006 Jul; 200(1):38-49. PubMed ID: 16624294
[TBL] [Abstract][Full Text] [Related]
20. Cell permeable HMGB1-binding heptamer peptide ameliorates neurovascular complications associated with thrombolytic therapy in rats with transient ischemic stroke.
Li M; Chen S; Shi X; Lyu C; Zhang Y; Tan M; Wang C; Zang N; Liu X; Hu Y; Shen J; Zhou L; Gu Y
J Neuroinflammation; 2018 Aug; 15(1):237. PubMed ID: 30139371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
